Trk receptor alterations in Alzheimer's disease

Molecular Brain Research

Volumn 42, Issue 1, 1996, Pages 1-17

  Connor, B ^a   Young, D ^a   Lawlor, P ^a   Gai, W ^c   Waldvogel, H ^b   Faull, R L M ^b   Dragunow, M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Astrocyte; Downs syndrome; Hippocampus; Human brain; Neurodegeneration; Neurotrophin; Senile plaque

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN RECEPTOR; MESSENGER RNA; NEUROTROPHIN; PROTEIN TYROSINE KINASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE;

EID: 0030297630     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00040-X     Document Type: Article

References (114)

1. [1] Alderson, R.F., Alterman, A.L., Barde, Y. and Lindsay, R.M., Brain-derived neurotrophic factor increases survival and differentiated function of rat septal cholinergic neurons in culture, Neuron, 5 (1990) 297-306.
2. [2] Allen, S.J., MacGowan, S.H., Treanor, J.J.S., Feeny, R., Wilcock, G.K. and Dawbarn, D., Normal β-NGF content in Alzheimer's disease cerebral cortex and hippocampus, Neurosci. Lett., 131 (1991) 135-139.
3. [3] Anderson, A.J., Cummings, B.J. and Cotman, C.W., Increased immunoreactivity for Jun-and Fos-related proteins in Alzheimer's disease: association with pathology, Exp. Neurol., 125 (1994) 286-295.
4. [4] Appel, S.H., A unifying hypothesis for the cause of Amyotrophic lateral sclerosis, Parkinsonism, and Alzheimer's disease, Ann. Neurol., 10 (1981) 499-505.
5. [5] Araujo, D.M., Chabot, J.G. and Quirion, R., Potential neurotrophic factors in the mammalian central nervous system: functional significance in the developing and aging brain, Int. Rev. Neurobiol., 32 (1990) 141-173.
6. [6] Araujo, D.M. and Cotman, C.W., β-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease, Brain, 569 (1992) 141-145.
7. [7] Barbacid, M., Lamballe, F., Pulido, D. and Klein, R., The trk family of tyrosine protein kinase receptors, Biochim. Biophys. Acta, 1072 (1991) 115-127.
8. [8] Barker, P.A. and Murphy, R.A., The nerve growth factor receptor: a multicomponent system that mediates the actions of the neurotrophin family of proteins, Mol. Cell. Biochem., 110 (1992) 1-15.
9. [9] Bartlett, P.F., Kilpatrick, T.J., Richards, L.J., Talman, P.S. and Murphy, M., Regulation of the early development of the nervous system by growth factors, Pharmacol. Ther., 64 (1994) 371-393.
10. [10] Beck, K.D., Lamballe, F., Klein, R., Barbacid, M., Schauwecker, P.E., McNeill, T.H., Finch, C.E., Hefti, F. and Day, J.R., Induction of noncatalytic TrkB neurotrophin receptors during axonal sprouting in the adult hippocampus, J. Neurosci., 13 (1993) 4001-4014.
11. [11] Blass, J.P., Ko, L. and Wisniewski, H.M., Pathology of Alzheimer's disease, Psychiatry Clin. N. Am., 14 (1991) 397-416.
12. [12] Bothwell, M., Functional interactions of neurotrophins and neurotrophin receptors, Annu. Rev. Neurosci., 18 (1995) 223-253.
13. [13] Butcher, L.L. and Woolf, N.J., Neurotrophic agents may exacerbate the pathological cascade of Alzheimer's disease, Neurobiol. Aging, 10 (1989) 557-570.
14. [14] Calry, D.O. and Reichardt, L.F., An alternatively splice form of the nerve growth factor receptor TrkA confers an enhanced response to neurotrophin 3, Proc. Natl. Acad. Sci. USA, 91 (1994) 11133-11137.
15. [15] Cavicchioli, L., Flanigan, T.P., Vantini, G., Fusco, M., Polato, P., Toffano, G., Walsh, F.S. and Leon, A., NGF amplifies expression of NGF receptor messenger RNA in forebrain cholinergic neurons of rats, Eur. J. Neurosci., 1 (1989) 258-261.
16. [16] Chao, M.V. and Hempstead, B.L., p75 and Trk: a two-receptor system, Trends Neurosci., 18 (1995) 321-326.
17. [17] Condorelli, D.F., Dell'Albani, P., Mudo, G., Timmusk, T. and Belluardo, N., Expression of neurotrophins and their receptors in primary astroglial cultures: induction by cyclic AMP-elevating agents, J. Neurochem., 63 (1994) 509-516.
18. [18] Crutcher, K.A., Scott, S.A., Liang, S., Everson, W.V. and Weingartner, J., Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease, J. Neurosci., 13 (1993) 2540-2550.
19. [19] Cuello, A.C. and Sofroniew, M.V., The anatomy of the CNS cholinergic neurons, Trends Neurosci., 7 (1984) 74-78.
20. [20] Cuello, C.A., Trophic responses of forebrain cholinergic neurons: a discussion, Prog. Brain Res., 98 (1993) 265-277.
21. [21] Dechant, G., Rodriguez-Tebar, A. and Barde, Y., Neurotrophin receptors, Prog. Neurobiol., 42 (1994) 347-352.
22. [22] Dragunow, M., Beilharz, E., Sirimanne, E., Lawlor, P., Williams, C., Bravo, R. and Gluckman, P., Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to young rat brain, Mol. Brain Res., 25 (1994) 19-33.
23. [23] Dragunow, M., Faull, R.L.M., Lawlor, P., Beilharz, E.J., Singleton, K., Walker, E.B. and Mee, E., In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes, NeuroReport, 6 (1995) 1053-1057.
24. [24] Eide, F.F., Lowenstein, D.H. and Reichardt, L.F., Neurotrophins and their receptors: current concepts and implications for neurological disease, Exp. Neurol., 121 (1993) 200-214.
25. [25] Falkenberg, T., Ernfors, P., Persson, H. and Lindfors, N., Cortical transsynaptic activation of tyrosine kinase receptor TrkB messenger RNA expression in rat hippocampus, Neuroscience, 51 (1992) 883-889.
26. [26] Frederickson, R.C.A., Astroglia in Alzheimer's disease, Neurobiol. Aging, 13 (1992) 239-253.
27. [27] Frisen, J., Verge, V.M.K., Fried, K., Risling, M., Persson, H., Trotter, J., Hokfelt, T. and Lindholm, D., Characterization of glial trkB receptors: differential response to injury in the central and peripheral nervous systems, Proc. Natl. Acad. Sci. USA, 90 (1993) 4971-4975.
28. [28] Fukumoto, H., Kakihana, M. and Suno, M., Recombinant human basic fibroblast growth factor (rhFGF) induces secretion of nerve growth factor (NGF) in cultured rat astroglial cells, Neurosci. Lett., 122 (1991) 221-224.
29. [29] Gadient, R.A., Cron, K.C. and Otten, U., Interleukin-1β and tumor necrosis factor-α synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes, Neurosci. Lett., 117 (1990) 335-340.
30. [30] Gasser, U.E., Weskamp, G., Otten, U. and Dravid, A.R., Time course of the elevation of nerve growth factor (NGF) content in the hippocampus and septum following lesions of the septohippocampal pathway in rats, Brain, 376 (1986) 351-356.
31. [31] Goedert, M., Fine, A., Hunt, S.P. and Ullrich, A., Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease, Mol. Brain Res., 1 (1986) 85-92.
32. [32] Gomez-Pinilla, F., Lee, J.W. and Cotman, C.W., Basic FGF in adult rat brain: cellular distribution and response to entorhinal lesion and fimbra-fornix transection, J. Neurosci., 12 (1992) 345-355.
33. [33] Hantzopoulos, P.A., Suri, C., Glass, D.J., Goldfarb, M.P. and Yancopoulos, G.D., The low affinity NGF receptor, p75, can collaborate with each of the trks to potentiate functional responses to the neurotrophins, Neuron, 13 (1994) 187-201.
34. [34] Hardy, J.A. and Higgins, G.A., Alzheimer's disease: the amyloid cascade hypothesis, Science, 256 (1992) 184-185.
35. [35] Hefti, F., Is Alzheimer's disease caused by lack of nerve growth factor? Ann. Neurol., 13 (1983) 109-110.
36. [36] Hefti, F. and Mash, D.C., Localisation of nerve growth factor receptors in the normal human brain and in Alzheimer's disease, Neurobiol. Aging, 10 (1989) 75-87.
37. [37] Hellweg, R., Fischer, W., Hock, C., Gage, F.H., Bjorklund, A. and Thoenen, H., Nerve growth factor levels and choline acetyltransferase activity in the brain of aged rats with spatial memory impairments, Brain Res., 537 (1990) 123-130.
38. [38] Hempstead, B.L., Martin-Zanca, D., Kaplan, D.R., Parada, L.F. and Chao, M.V., High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor, Science, 350 (1991) 678-682.
39. [39] Higgins, G.A. and Mufson, E.J., NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease, Exp. Neurol., 106 (1989) 222-236.
40. [40] Hoehner, J.C., Olsen, L., Sandstedt, B., Kaplan, D.R. and Pahlman, S., Association of neurotrophin receptor expression and differentiation in human neuroblastoma, Am. J. Pathol., 147 (1995) 102-113.
41. [41] Hoke, A., Canning, D.R., Malemud, C.J. and Silver, J., Regional differences in reactive gliosis induced by substrate-bound β-amyloid, Exp. Neurol., 130 (1994) 56-66.
42. [42] Holtzman, D.M., Kilbridge, J., Li, Y., Cunningham, E.T., Lenn, N.J., Clary, D.O., Reichardt, L.F. and Mobley, W.C., TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons, J. Neurosci., 15 (1995) 1567-1576.
43. [43] Ip, N.Y. and Yancopoulos, G.D., Neurotrophic factors and their receptors, Ann. Neurol., 35 (1994) S13-S16.
44. [44] Jehan, F., Neveu, I., Naveilhan, P., Wion, D. and Brachet, P., Interactions between second messenger pathways influence NGF synthesis in mouse primary astrocytes, Brain Res., 672 (1995) 128-136.
45. [45] Jette, N., Cole, M.S. and Fahnestock, M., NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients, Mol. Brain Res., 25 (1994) 242-250.
46. [46] Jungbluth, S., Bailey, K. and Barde, Y.A., Purification and characterization of a brain-derived neurotrophic factor/neurotrophin-3 (BDNF/NT-3) heterodimer, Eur. J. Biochem., 221 (1994) 677-685.
47. [47] Kaplan, D.R., Hempstead, B.L., Martin-Zanca, D., Chao, M.V. and Parada, L.F., The trk proto-oncogene product: a signal transducing receptor for nerve growth factor, Science, 252 (1991) 554-557.
48. [48] Kaplan, D.R., Martin-Zanca, D. and Parada, L.F., Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF, Nature, 350 (1991) 158-160.
49. [49] Kerwin, J.M., Morris, C.M., Perry, R.H. and Perry, E.K., Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease, Neurosci. Lett., 143 (1992) 101-104.
50. [50] Klein, R., Conway, D., Parada, L.F. and Barbacid, M., The trkB tyrosine protein kinase receptor gene codes for a second neurogenic receptor that lacks the catalytic kinase domain, Cell, 61 (1990) 647-656.
51. [51] Klein, R., Nanduri, V., Jing, S., Lambelle, F., Tapley, P., Bryant, S., Cordon-Cardo, C., Jones, K.R., Reichardt, L.F. and Barbacid, M., The TrkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3, Cell, 66 (1991) 395-403.
52. [52] Klein, R., Parada, L.F., Coulier, F. and Barbacid, M., trkB, a novel tyrosine kinase receptor expressed during mouse neural development, EMBO J., 8 (1989) 3071-3079.
53. [53] Koliatsos, V.E., Applegate, M.D., Knusel, B., Junard, E.O., Burton, L.E., Mobley, W.C., Hefti, F. and Price, D., Recombinant human nerve growth factor prevents retrograde degeneration of axotomised basal forebrain cholinergic neurons in the rat, Exp. Neurol., 112 (1991) 161-173.
54. [54] Koliatsos, V.E., Clatterbuck, R.E., Gouras, G.K. and Price, D.L., Biological effects of nerve growth factor on lesioned basal forebrain neurons, Ann. NY Acad. Sci., 640 (1991) 102-109.
55. [55] Koliatsos, V.E., Clatterbuck, R.E., Nauta, H.J.W., Knusel, B., Burton, L.E., Hefti, F.F., Mobley, W.C. and Price, D.L., Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates, Ann. Neurol., 30 (1991) 831-840.
56. [56] Koliatsos, V.E., Price, D.L., Clatterbuck, R.E., Markowska, A.L., Olton, D.S. and Wilcock, B.J., Neurotrophic strategies for treating Alzheimer's disease: lessons from basic neurobiology and animal models, Ann. NY Acad. Sci., 640 (1991) 292-299.
57. [57] Kosik, K.S., Alzheimer plaques and tangles: advances on both fronts, Trends Neurosci., 14 (1991) 218-219.
58. [58] Lahiri, D.K. and Nall, C., Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1, Mol. Brain Res., 32 (1995) 233-240.
59. [59] Lapchack, P.A., Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease, Exp. Neurol., 124 (1993) 16-20.
60. [60] Lapchak, P.A. and Hefti, F., Effect of recombinant human nerve growth factor on presynaptic cholinergic function in rat hippocampal slices following partial septohippocampal lesions: measures of [H] acetylcholine synthesis, [H] acetylcholine release and choline acetyltransferase activity, Neuroscience, 42 (1991) 639-649.
61. [61] Li, B., Yokoyama, M., Dreyfus, C.F. and Black, I.B., NGF gene expression in actively growing brain glia, J. Neurosci., 11 (1991) 318-326.
62. [62] Lindsay, R.M., Neurotrophins and receptors, Prog. Brain Res., 103 (1994) 3-14.
63. [63] Lucidi-Phillipi, C.A. and Gage, F.H., The neurotrophic hypothesis and the cholinergic basal forebrain projection, Prog. Brain Res., 98 (1993) 241-249.
64. [64] Maisonpierre, P.C., Belluscio, L., Squinto, S., Ip, N.Y., Furth, M.E., Lindsay, R.M. and Yancopoulos, G.D., Neurotrophin-3: a neurotrophic factor related to NGF and BDNF, Science, 247 (1990) 1146-1451.
65. [65] Maness, L.M., Kastin, A.J., Webber, J.T., Banks, W.A., Beckman, B.S. and Zadina, J.E., The neurotrophins and their receptors: structure, function, and neuropathology, Neurosci. Biobehav. Rev., 18 (1994) 143-159.
66. [66] Mann, D.M., Is the pattern of nerve cell loss in aging and Alzheimer's disease real, or only apparent, selectivity? Neurobiol. Aging, 12 (1991) 340-343.
67. [67] Martin-Zanca, D., Mitra, G., Copeland, T. and Barbacid, M., Molecular and biochemical characterisation of the human trk proto-oncogene, Mol. Cell. Biol., 9 (1989) 24-33.
68. [68] Marx, J., NGF and Alzheimer's: hopes and fears, Science, 247 (1990) 408-410.
69. [69] Mattson, M.P., Barger, S.W., Cheng, B., Lieberburg, I., SmithSwintosky, V.L. and Rydel, R.E., β-amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease, Trends Neurosci., 16 (1993) 409-414.
70. [70] Meakin, S.O. and Shooter, E.M., The nerve growth factor family of receptors, Trends Neurosci., 15 (1992) 323-330.
71. [71] Mecocci, P., MacGarvey, U. and Beal, M.F., Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease, Ann. Neurol., 36 (1994) 747-751.
72. [72] Merlio, J., Ernfors, P., Kokaia, Z., Middlemas, D.S., Bengzon, J., Kokaia, M., Smith, M., Siesjo, B.K., Hunter, T., Lindvall, O. and Persson, H., Increased production of the TrkB protein tyrosine kinase receptor after brain insults, Neuron, 10 (1993) 151-164.
73. [73] Messamore, E., Bogdanovich, N., Schroder, H. and Winblad, B., Astrocytes associated with senile plaques possess muscarinic acetylcholine receptors, NeuroReport, 5 (1994) 1473-1476.
74. [74] Middlemas, D.S., Lindberg, R.A. and Hunter, T., TrkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors, Mol. Cell. Biol., 11 (1991) 143-153.
75. [75] Milward, E.A., Papadopoulos, R., Fuller, S.J., Moir, R.D., Small, D., Beyreuther, K. and Masters, C.L., The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth, Neuron, 9 (1992) 129-137.
76. [76] Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M., Crain, B.J., Brownlee, L.M., Vogel, F.S., Hughes, J.P., van Belle, G. and Berg, L., The Consortium to establish a registry for Alzheimer's disease (CERAD), Neurology, 41 (1991) 479-486.
77. [77] Mobley, W.C., Neve, R.L., Prusiner, S.B. and McKinley, M.P., Nerve growth factor increases mRNA levels for the prion protein and the β-amyloid protein precursor in developing hamster brain, Proc. Natl. Acad. Sci. USA, 85 (1988) 9811-9815.
78. [78] Mufson, E.J., Conner, J.M. and Kordower, J.H., Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis, NeuroReport, 6 (1995) 1063-1066.
79. [79] Mufson, E.J., Conner, J.M., Varon, S. and Kordower, J.H., Nerve growth factor-like immunoreactive profiles in the primate basal forebrain and hippocampal formation, J. Comp. Neurol., 341 (1994) 507-519.
80. [80] Mufson, E.J. and Kordower, J.H., Cortical neurons express nerve growth factor receptors in advancing age and Alzheimer's disease, Proc. Natl. Acad. Sci. USA, 89 (1992) 569-573.
81. [81] Murphy, G.M., Ellis, W.G., Lee, Y., Stultz, K.E., Shrivastava, R., Tinklenberg, J.R. and Eng, L.F., Astrocytic gliosis in the amygdala in Downs syndrome and Alzheimer's disease. Prog. Brain Res., 94 (1992) 475-484.
82. [82] Murray, K.D., Gall, C.M., Jones, E.G. and Isackson, P.J., Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease, Neuroscience, 60 (1994) 37-48.
83. [83] Nakagawara, A., Arima-Nakagawa, M., Scavarda, N.J., Azar, C.G., Cantor, A.B. and Brodeur, G.M., Association between high levels of expression of the trk gene and favourable outcome in human neuroblastoma, N. Engl. J. Med., 328 (1993) 847-854.
84. [84] Nalbantoglu, J., β-amyloid protein in Alzheimer's disease, Can. J. Neurol. Sci., 18 (1991) 424-427.
85. [85] Nieto-Sampedro, M. and Mora, F., Active microglia, sick astroglia and Alzheimer type dementia's, NeuroReport, 5 (1994) 375-380.
86. [86] Olson, L., NGF and the treatment of Alzheimer's disease, Exp. Neurol., 124 (1993) 5-15.
87. [87] Palacios, G., Mengod, G., Tortosa, A., Ferrer, I. and Palacios, J.M., Increased β-amyloid precursor protein expression in astrocytes in the gerbil hippocampus following ischaemia: association with proliferation of astrocytes. Eur. J. Neurosci., 7 (1995) 501-510.
88. [88] Phelps, C.H., Neural plasticity in aging and Alzheimer's disease: some selected comments, Prog. Brain Res., 86 (1990) 3-9.
89. [89] Phillips, H.S., Hains, J.M., Armanini, M., Laramee, G.R., Johnson, S.A. and Winslow, J.W., BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease, Neuron, 7 (1991) 695-702.
90. [90] Phillips, H.S., Hains, J.M., Laramee, G.R., Rosenthal, A. and Winslow, J.W., Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons, Science, 250 (1990) 290-293.
91. [91] Pike, C.J., Walencewicz-Wasserman, A.J., Kosmoski, J., Cribbs, D.H., Glabe, C.G. and Cotman, C.W., Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity, J. Neurochem., 64 (1995) 253-265.
92. [92] Potter, H., The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease, Prog. Brain Res., 94 (1992) 447-458.
93. [93] Rabizadeh, S., Bitler, C.M., Butcher, L.L. and Bredesen, D.E., Expression of the low-affinity nerve growth factor receptor enhances β-amyloid peptide toxicity, Proc. Natl. Acad. Sci. USA, 91 (1994) 10703-10706.
94. [94] Rabizadeh, S., Oh, J., Zhong, L., Yang, J., Bitler, C.M., Butcher, L.L. and Bredesen, D.E., Induction of apoptosis by the low-affinity NGF receptor, Science, 261 (1993) 345-348.
95. [95] Regland, B. and Gottfries, C., The role of amyloid β-protein in Alzheimer's disease, Lancet, 340 (1992) 467-468.
96. [96] Rodriguez-Tebar, A., Dechant, G. and Barde, Y.-A., Neurotrophins: structural relatedness and receptor interactions, Phil. Trans. Roy. Soc. Lond. Series B: Biol. Sci., 331 (1991) 255-258.
97. [97] Rylett, R.J. and Williams, L.R., Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS, Trends Neurosci., 17 (1994) 486-489.
98. [98] Saitiel, A.R. and Decker, S.J., Cellular mechanisms of signal transduction for neurotrophins, BioEssays, 16 (1994) 405-411.
99. [99] Saitoh, T., Horsburgh, K. and Masliah, E., Hyperactivation of signal transduction systems in Alzheimer's disease, Ann. NY Acad. Sci., 640 (1991) 34-41.
100. [100] Scott, S.A., Mufson, E.J., Weingartner, J.A., Skau, K.A. and Crutcher, K.A., Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis, J. Neurosci., 15 (1995) 6213-6221.
101. [101] Selkoe, D.J., Amyloid protein and Alzheimer's disease, Sci. Am., November (1991) 40-47.
102. [102] Selkoe, D.J., Physiological production of the β-amyloid protein and mechanism of Alzheimer's disease, Trends Neurosci., 16 (1993) 403-408.
103. [103] Soppet, D., Escandon, E., Maragos, J., Middlemas, D.S., Reid, S.W., Blair, J., Burton, L.E., Stanton, B.R., Kaplan, D.R., Hunter, T., Nikolics, K. and Parada, L.F., The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor, Cell, 65 (1991) 895-903.
104. [104] Squinto, S.P., Stitt, T.N., Aldrich, T.H., Davis, S., Bianco, S.M., Radziejewski, P., Glass, D.J., Masiakowski, P., Furth, M.E., Valenzuela, D.M., DiStefano, P.S. and Yancopoulos, G.D., TrkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor, Cell, 65 (1991) 885-893.
105. [105] Su, J.H., Anderson, A.J., Cummings, B.J. and Cotman, C.W., Immunohistochemical evidence for apoptosis in Alzheimer's disease, NeuroReport, 5 (1994) 2529-2533.
106. [106] Thoenen, H., The changing scene of neurotrophic factors, Trends Neurosci., 14 (1991) 165-170.
107. [107] Tuszynski, M.H., Sang, H., Amaral, D.G. and Gage, F.H., Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration, J. Neurosci., 10 (1990) 3604-3614.
108. [108] Ullrich, A. and Schlessinger, J., Signal transduction by receptors with tyrosine kinase activity, Cell, 61 (1990) 203-212.
109. [109] Vijayan, V.K., Geddes, J.W. anderson, K.J., Chang-Chui, H., Ellis, W.G. and Cotman, C.W., Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation, Exp. Neurol., 112 (1991) 72-78.
110. [110] Wainer, B.H., Neurotrophic factors and Alzheimer's disease, Neurobiol. Aging, 10 (1989) 540-542.
111. [111] Whittemore, S.R. and Seiger, A., The expression, localisation and functional significance of β-nerve growth factor in the central nervous system, Brain Res. Rev., 12 (1987) 439-464.
112. [112] Widmer, H.R., Knusel, B. and Hefti, F., Stimulation of phosphatidylinositol hydrolysis by brain-derived neurotrophic factor and neurotrophin-3 in rat cerebral cortical neurons developing in culture, J. Neurochem., 59 (1992) 2113-2124.
113. [113] Yoshida, K. and Gage, F.H., Cooperative regulation of nerve growth factor synthesis and secretion in fibroblasts and astrocytes by fibroblast growth factor and other cytokines, Brain Res., 569 (1992) 14-25.
114. [114] Zhou, J., Valletta, J.S., Grimes, M.L. and Mobley, W.C., Multiple levels for regulation of trkA in PC12 cells by nerve growth factor, J. Neurochem., 65 (1995) 1146-1156.